SCHEMBL18201115

SCHEMBL18201115

c1ccc(-c2cccc(-c3nc(-c4ccc(-c5ccc(-c6nc7ccccc7c7c6ccc6ccccc67)cc5)cc4)c4ccccc4n3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ATM Q13315 1/20 0.51
WHR1 P49842 1/20 0.42
NUDT1 P36639 3/20 0.40
ADORA2A P29274 2/20 0.40
NR1I3 Q14994 3/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
VDR P11473 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2B6 P20813 1/20 0.38
AHR P35869 1/20 0.38
MAPT P10636 4/20 0.38
NPC1 O15118 2/20 0.38
LMNA P02545 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18346962 1.00 MEN1 (0.51) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18201124 1.00 MEN1 (0.51) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18200354 0.99 MEN1 (0.50) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18200762 0.99 MEN1 (0.50) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18201125 0.99 MEN1 (0.50) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18201118 0.96 MEN1 (0.53) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18200591 0.96 MEN1 (0.53) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18200598 0.96 MEN1 (0.53) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18201114 0.96 MEN1 (0.53) MEN1KMT2AATMWHR1NUDT1
SCHEMBL18200924 0.96 MEN1 (0.53) MEN1KMT2AATMWHR1NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MEN1 1750/4885KMT2A 1104/4885ATM 2923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.